Dren Bio Stock
Dren Bio focuses on protein engineering technologies for depletion of cells, protein aggregates, and other disease-causing agents.
Sign up today and learn more about Dren Bio Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Dren Bio Stock
Dren Bio is a biotechnology company with a portfolio of attractive projects focused on powerful protein engineering technologies for the depletion of cells, protein aggregates, and other disease-causing agents. It is a holding company business model aimed at creating value with multiple projects as stand-alone assets.
Funding History
July 2019 | $5.1M |
---|---|
October 2020 | $60.0M |
March 2022 | $62.5M |
Management
CEO and Co-Fonder
Nenad Tomasevic
Co-Founder, CFO
John Wesley
Press
businesswire - Feb, 18 2024
Dren Bio Strengthens Leadership Team with Appointment of Amit Mehta, Ph.D., as Chief Operating Officer and Chief ...prnewswire - Dec, 23 2023
The Leukemia & Lymphoma Society Awards $65 Million in ...prnewswire - Dec, 23 2023
Large Granular Lymphocyte Leukemia Market is Projected to ...startuparound - Jun, 15 2022
Dren Bio Lands $65M Series B Funding Roundvcaonline - Oct, 17 2020
Venture Capital Database 2020 Now Available!